Given that MYCN is a key oncogenic driver in high-risk neuroblastoma and governs a broad transcriptional network, we hypothesized that NIPBL may colocalize with MYCN in the neuroblastoma genome. The gene discussed is NIPBL; the disease is neuroblastoma.